SÜSS MicroTec (SMHN) Q1 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q1 2025 earnings summary
21 Nov, 2025Executive summary
Q1 2025 sales rose 31.8% year-over-year to €123.2 million, the second-best quarter in company history, with both Advanced Backend and Photomask Solutions contributing.
Order intake was €88.1 million, down 10.4% year-over-year after a record Q4 2024, resulting in a book-to-bill ratio of 0.72.
Net profit from continuing operations increased 44.2% to €15.0 million; EPS up 44.4% to €0.78.
Asia/Pacific remains the largest market, accounting for up to 83.6% of sales.
The order book stands at €392.7 million, providing visibility for the next two to three quarters.
Financial highlights
Gross profit margin was 37.9%, down 1.2 percentage points year-over-year, due to product/customer mix and Taiwan site ramp-up costs.
EBIT margin improved by 0.7 percentage points to 16.6%, with EBIT at €20.4 million, and free cash flow rose to €8.9 million.
CapEx was €1.7 million in Q1, expected to rise as Taiwan site investments accelerate.
Cash and cash equivalents increased by €7.5 million to €143.7 million; net cash position at €130.0 million.
Equity ratio improved to 57.1%, up from 55.9% at year-end 2024.
Outlook and guidance
Full-year 2025 guidance confirmed: sales €470–510 million, gross margin 39–41%, EBIT margin 15–17%.
Q1 sales and order book provide a solid basis for achieving 2025 targets.
Macroeconomic risks have increased, especially from US tariffs, exchange rate volatility, and potential customer project delays.
Latest events from SÜSS MicroTec
- Record Q1 order intake drives optimism for 2026 despite weak sales and profit.SMHN
Q1 20267 May 2026 - Record 2025 sales and new product launches support ambitious 2030 growth targets.SMHN
German Select VII Conference15 Apr 2026 - Record 2025 sales and strategic investments set the stage for double-digit growth through 2030.SMHN
Investor presentation13 Apr 2026 - Record 2025 sales of €503.2M; 2026 outlook signals lower sales and margins amid higher R&D.SMHN
Q4 20252 Apr 2026 - Sales up 45.6%, EBIT margin at 15.6%, and guidance raised on strong order momentum.SMHN
Q2 20242 Feb 2026 - Record sales and margins in 2024 set a strong outlook for 2025 despite one-off costs.SMHN
Q4 202423 Dec 2025 - Record sales and EBIT growth offset by lower order intake and margin pressure, prompting guidance cuts.SMHN
Q2 202523 Nov 2025 - Sales targeted at €750–900 million and 43–45% margin by 2030, led by innovation and services.SMHN
CMD 202521 Nov 2025 - Margin pressure and lower net income prompt guidance cut, but Q4 order rebound expected.SMHN
Q3 202513 Nov 2025